
Laura Lynne Stockton
Examiner (ID: 15659, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1201, 2899, 1626, 1613, 1614, 1646 |
| Total Applications | 3283 |
| Issued Applications | 2225 |
| Pending Applications | 331 |
| Abandoned Applications | 760 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17807398
[patent_doc_number] => 20220259233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CANNABINOID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/626518
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626518
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626518 | Cannabinoid derivatives | Jul 9, 2020 | Issued |
Array
(
[id] => 17595199
[patent_doc_number] => 20220144772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHOD FOR PURIFYING WASTE N-METHYL-2-PYRROLIDONE MIXTURE SOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/604049
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604049
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604049 | Method for purifying waste N-methyl-2-pyrrolidone mixture solution | Jul 6, 2020 | Issued |
Array
(
[id] => 16390923
[patent_doc_number] => 20200331864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => 1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/918234
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 1254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918234 | 1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES | Jun 30, 2020 | Abandoned |
Array
(
[id] => 20172956
[patent_doc_number] => 12391688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Imidazopyridine derivatives as IL-17 modulators
[patent_app_type] => utility
[patent_app_number] => 17/614067
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12710
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614067 | Imidazopyridine derivatives as IL-17 modulators | Jun 23, 2020 | Issued |
Array
(
[id] => 19731194
[patent_doc_number] => 12209185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Color material compound
[patent_app_type] => utility
[patent_app_number] => 17/628312
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 11755
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628312 | Color material compound | Jun 22, 2020 | Issued |
Array
(
[id] => 17791938
[patent_doc_number] => 20220251029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMPOUND, COMPOSITION, FILM, LAMINATE, AND DISPLAY DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/628980
[patent_app_country] => US
[patent_app_date] => 2020-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628980 | Compound, composition, film, laminate, and display device | Jun 21, 2020 | Issued |
Array
(
[id] => 17929677
[patent_doc_number] => 20220324802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHOD FOR PURIFYING AN ORGANIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/620854
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620854 | Recrystallisation of 5-methoxy-N,N-dimethyltryptamine(5-MeO-DMT) | Jun 18, 2020 | Issued |
Array
(
[id] => 16512898
[patent_doc_number] => 20200392156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => AMINOPYRIMIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/904073
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904073 | AMINOPYRIMIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS | Jun 16, 2020 | Abandoned |
Array
(
[id] => 17749588
[patent_doc_number] => 20220227792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => CARBORANE HYDROXAMIC ACID MATRIX METALLOPROTEINASE AGENTS FOR BORON NEUTRON CAPTURE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/616559
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616559 | CARBORANE HYDROXAMIC ACID MATRIX METALLOPROTEINASE AGENTS FOR BORON NEUTRON CAPTURE THERAPY | Jun 14, 2020 | Abandoned |
Array
(
[id] => 16525184
[patent_doc_number] => 20200399264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/902080
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 509
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902080 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | Jun 14, 2020 | Abandoned |
Array
(
[id] => 17829965
[patent_doc_number] => 20220267269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOUNDS FOR THE MODULATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)
[patent_app_type] => utility
[patent_app_number] => 17/618873
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618873 | COMPOUNDS FOR THE MODULATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) | Jun 11, 2020 | Abandoned |
Array
(
[id] => 16343461
[patent_doc_number] => 20200308111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => Cationic Lipid
[patent_app_type] => utility
[patent_app_number] => 16/897752
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897752 | Cationic lipid | Jun 9, 2020 | Issued |
Array
(
[id] => 17704459
[patent_doc_number] => 20220204465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PROCESS FOR THE CARBONYLATION OF EPOXIDES
[patent_app_type] => utility
[patent_app_number] => 17/607737
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607737
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607737 | PROCESS FOR THE CARBONYLATION OF EPOXIDES | Jun 4, 2020 | Abandoned |
Array
(
[id] => 20679543
[patent_doc_number] => 20260118357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-30
[patent_title] => TETRA-FUNCTIONAL CHEMICAL PROBE AND METHOD FOR IDENTIFYING TARGET MEMBRANE PROTEIN FROM LIVING CELL OR LIVING TISSUE BY USING SAID PROBE
[patent_app_type] => utility
[patent_app_number] => 17/616921
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 336
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616921 | TETRA-FUNCTIONAL CHEMICAL PROBE AND METHOD FOR IDENTIFYING TARGET MEMBRANE PROTEIN FROM LIVING CELL OR LIVING TISSUE BY USING SAID PROBE | Jun 4, 2020 | Pending |
Array
(
[id] => 16483918
[patent_doc_number] => 20200377519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => HEPATITIS B ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/891401
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891401 | Hepatitis B antiviral agents | Jun 2, 2020 | Issued |
Array
(
[id] => 16885275
[patent_doc_number] => 20210171470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/888484
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888484 | Compounds and methods for the targeted degradation of androgen receptor | May 28, 2020 | Issued |
Array
(
[id] => 20438627
[patent_doc_number] => 12509454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Thiadiazolyl derivatives
[patent_app_type] => utility
[patent_app_number] => 17/615123
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66398
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615123 | Thiadiazolyl derivatives | May 28, 2020 | Issued |
Array
(
[id] => 18484860
[patent_doc_number] => 20230212169
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-07-06
[patent_title] => PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/615012
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615012 | Pyridopyrimidines derivatives as P2X3 inhibitors | May 27, 2020 | Issued |
Array
(
[id] => 18484860
[patent_doc_number] => 20230212169
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-07-06
[patent_title] => PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/615012
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615012 | Pyridopyrimidines derivatives as P2X3 inhibitors | May 27, 2020 | Issued |
Array
(
[id] => 16468157
[patent_doc_number] => 20200369694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => NOVEL CATALYSTS FOR THE SYNTHESIS OF OLIGOMERIC ISOCYANATES
[patent_app_type] => utility
[patent_app_number] => 15/930756
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930756
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930756 | NOVEL CATALYSTS FOR THE SYNTHESIS OF OLIGOMERIC ISOCYANATES | May 12, 2020 | Abandoned |